Swedish bioinformatics group grabs $840K to fuel growth, report says

Qlucore, a Swedish maker of software for analyzing scientific data in academic and pharma labs, is eyeing expansion in the U.S. The bioinformatics outfit has raised $840,000 from Stockholm-based venture firm GLD Invest, GenomeWeb reports.

With the financing, Qlucore aims to establish a U.S. sales office and support further development of its Omics Explorer software for slicing and dicing data from gene expression, microarray, real-time PCR, DNA methylation and other types of scientific data, GenomeWeb reports, citing a company announcement. The software development will take place in Sweden.

Qlucore, founded in 2007, grew from a research project at Lund University in Sweden involving the mathematics and clinical genetics departments. Taking on a problem common in many research settings, the collaborators tackled the issue of conceptualizing oodles of high-dimensional data from microarray gene expression analysis. The result: The company's core software visualizes data in 3D to help users pinpoint hidden patterns, according to its website.   

As GenomeWeb reports, Qlucore has customers in 17 countries around the world, and users include researchers in academia, pharma and biotech. And the company isn't the only scientific software group in Europe seeking expansion in the U.S.; Budapest-based ChemAxon announced its new East Coast headquarters in Cambridge, MA, in September.   

- here's GenomeWeb's report

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.